Share on StockTwits

SurModics (NASDAQ:SRDX) is scheduled to issue its quarterly earnings data on Thursday, January 30th. SurModics has set its FY13 guidance at $0.80-0.92 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.

SurModics (NASDAQ:SRDX) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.04. The company had revenue of $14.30 million for the quarter, compared to the consensus estimate of $14.32 million. During the same quarter in the previous year, the company posted $0.17 earnings per share. The company’s revenue for the quarter was up 3.3% on a year-over-year basis.

SurModics (NASDAQ:SRDX) opened at 23.23 on Wednesday. SurModics has a 52 week low of $19.24 and a 52 week high of $27.98. The stock’s 50-day moving average is $24.49 and its 200-day moving average is $22.87. The company has a market cap of $319.1 million and a P/E ratio of 22.89.

A number of analysts have recently weighed in on SRDX shares. Analysts at Zacks upgraded shares of SurModics from an “underperform” rating to a “neutral” rating in a research note to investors on Wednesday, January 8th. They now have a $26.00 price target on the stock.

SurModics, Inc (NASDAQ:SRDX) is a provider of drug delivery and surface modification technologies to the healthcare industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.